| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/21/2008 | US20080047034 Nucleic acid molecules encoding novel bacillus thuringiensis Cry2Ae insecticidal proteins, plant cells, plant or seeds comprising the nucleic acid molecules and methods of using same |
| 02/21/2008 | US20080047031 Novel FRT recombination sites and methods of use |
| 02/21/2008 | US20080047026 by obtaining a population of cells from a sample and sorting the population of cells based on the presence of CD34 and the amount of a selected slow-cycling cell marker expressed by each cell, |
| 02/21/2008 | US20080045702 Self-processing plants and plant parts |
| 02/21/2008 | US20080045700 Canine CD20 Compositions |
| 02/21/2008 | US20080045699 Interleukin-1 Related Gene and Protein |
| 02/21/2008 | US20080045696 DNA Molecules Encoding L-Glutamate-Gated Chloride Channels From Rhipicephalus Sanguineus |
| 02/21/2008 | US20080045695 Fusion Protein Suitable to be Expressed High Effectively and the Production Method thereof |
| 02/21/2008 | US20080045608 Gene Encoding a Guanine Nucleotide Exchange Factor Binding to Rhoa |
| 02/21/2008 | US20080045607 Compositions and Methods for Treatment of Protein Misfolding Diseases |
| 02/21/2008 | US20080045591 (E)-7,7-Dimethyl-1-(4-hydroxy-3-methoxyphenyl)-oct-1-ene-3,5-dione; (E)-1-(4-Hydroxy-3-methoxyphenyl)-6-methyl-hept-1-ene-3,5-dione; prophylaxis of hypersensitivity, smooth muscle disorders, spasmodic conditions, allergic conditions, inflammatory conditions and/or pain |
| 02/21/2008 | US20080045571 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2008 | US20080045454 Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same |
| 02/21/2008 | US20080045453 Method of producing biologically active vitamin K dependent proteins by recombinant methods |
| 02/21/2008 | US20080045451 Novel thymidylate synthase mutants |
| 02/21/2008 | US20080045445 Modulating Notch1 Signaling Pathway for Treating Neuroendocrine Tumors |
| 02/21/2008 | US20080044907 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 02/21/2008 | US20080044906 Modified Gene-Silencing Nucleic Acid Molecules and Uses Thereof |
| 02/21/2008 | US20080044905 Promoters functional in plant plastids |
| 02/21/2008 | US20080044904 Glyphosate N-acetyltransferase (GAT) confers glyphosate resistance when expressed in plastids |
| 02/21/2008 | US20080044903 Gene transfer methods |
| 02/21/2008 | US20080044902 Blood brain barrier device |
| 02/21/2008 | US20080044901 Method of Inducing the Differentiation of Embryonic Stem Cells Into Nerve by Serum-Free Suspension Culture |
| 02/21/2008 | US20080044900 Scaffolds for cell transplantation |
| 02/21/2008 | US20080044899 Differentiated Cells Originating in Precursor Fat Cells and Method of Acquiring the Same |
| 02/21/2008 | US20080044898 Expression vector comprising nucleotide sequences which code plant regulatory sequences; for use in controlling root length, senecense and/or water and nutrient uptake |
| 02/21/2008 | US20080044874 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044873 Nucleic acid with beta-keto acyl-ACP synthase (KS) activity, chain length factor (CLF) activity, acyl transferase (AT) activity, and enoyl ACP-reductase (ER) activity; biosynthesis of polyunsaturated fatty acids (PUFAs) |
| 02/21/2008 | US20080044872 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044871 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044870 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044869 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms; plants and microorganisms that produce lipids |
| 02/21/2008 | US20080044867 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof |
| 02/21/2008 | US20080044856 Thermostable proteins and methods of making and using thereof |
| 02/21/2008 | US20080044855 System for regulated and enhanced baculovirus mediated transient transgene expression in mammalian cells |
| 02/21/2008 | US20080044848 Placental niche and use thereof to culture stem cells |
| 02/21/2008 | US20080044847 Blood-Brain Barrier Model |
| 02/21/2008 | US20080044845 Method for Obtaining a Singular Cell Model Capable of Reproducing in Vitro the Metabolic Idiosyncrasy of Humans |
| 02/21/2008 | US20080044844 Populations Of Cells And Devices And Systems Including Same |
| 02/21/2008 | US20080044835 Mammalian chemokine reagents |
| 02/21/2008 | US20080044817 Methods for Producing Recombinant Proteins |
| 02/21/2008 | US20080044807 Method of Detecting Hepatitis C Virus |
| 02/21/2008 | US20080044803 Platelet additive solution |
| 02/21/2008 | US20080044448 Formed by combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject |
| 02/21/2008 | US20080044447 Combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject |
| 02/21/2008 | US20080044441 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer |
| 02/21/2008 | US20080044432 Mammalian receptor proteins; related reagents and methods |
| 02/21/2008 | US20080044428 Glycosylphosphatidylinositol Glycan Signalling Via Integrins Functioning as Glycan Specific Receptors |
| 02/21/2008 | US20080044426 Novel Atypical Pneumonia-Causing Virus |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044424 Antagonists of protease activated receptor-1 (par1) |
| 02/21/2008 | US20080044422 CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses |
| 02/21/2008 | US20080044421 Methods of using death receptor ligands and CD20 antibodies |
| 02/21/2008 | US20080044420 Anti-IL-13 antibodies, compositions, methods and uses |
| 02/21/2008 | US20080044418 Tumor Antigens and Uses Thereof |
| 02/21/2008 | US20080044417 Cancer, autoimmune and inflammatory disease, vaccines; binds to the extracellular domain of native human Fc gamma RIIB with greater affinity than to the extracellular domain of native human Fc gamma RIIA |
| 02/21/2008 | US20080044415 Hepatocyte growth factor receptor antagonists and uses thereof |
| 02/21/2008 | US20080044414 IL-1beta binding antibodies and fragments thereof |
| 02/21/2008 | US20080044411 Human glp-1 mimetibodies, compositions, methods and uses |
| 02/21/2008 | US20080044410 Immunoglobulin against growth differentiation factor -8 (GDF-8) for use in the prevention and treatment of bone, muscular, nervous system and obesity; muscle enhancement; disorders of insulin metabolism |
| 02/21/2008 | US20080044408 Diagnosis, therapy of cancerous diseases; using cancerous disease modifying antibodies |
| 02/21/2008 | US20080044407 Mage-a3/hpv 16 peptide vaccines for head and neck cancer |
| 02/21/2008 | US20080044403 Immune Markers Used for Diagnosis and Therapy in Connection With Transplant Reactions |
| 02/21/2008 | US20080044395 In Vitro Method for Isolating, Proliferating and Differentiating Germ-Line Stem Cells |
| 02/21/2008 | US20080044394 Methods for genetic modification of hematopietic progenitor cells and uses of the modified cells |
| 02/21/2008 | US20080044393 Retinal dystrophin transgene and methods of use thereof |
| 02/21/2008 | US20080044392 Isolation of Stem Cell-Like Cells and Use Thereof |
| 02/21/2008 | US20080044391 Different dendritic cell subsets |
| 02/21/2008 | US20080044385 Novel Modified Galectin 8 Proteins and Use Thereof |
| 02/21/2008 | US20080044383 increasing engraftment potential of a cell, treating or alleviating a symptom of an immune disorder, tissue injury or cancer by administering to a subject, e.g. human a composition comprising the cells; CD34 and CD44 |
| 02/21/2008 | US20080040973 Transgenic crop plants with improved stress tolerance |
| 02/21/2008 | US20080040972 Transgenic expression; chimera; herbicide resistance, insect resistance; disease resistance; cells, seeds |
| 02/21/2008 | CA2853387A1 Nucleic acid encoding n-methylputrescine oxidase and uses thereof |
| 02/21/2008 | CA2690751A1 Methods and kits for evaluating and measuring the oncological status of tissue samples in three-dimensional physiological matrices |
| 02/21/2008 | CA2661023A1 Prlr-specific antibody and uses thereof |
| 02/21/2008 | CA2660519A1 Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors |
| 02/21/2008 | CA2660321A1 Differential labeling of cells |
| 02/21/2008 | CA2659252A1 Plants with enhanced size and growth rate |
| 02/21/2008 | CA2658050A1 Diagnosis and treatment of cancer using anti-desmoglein 3 antibodies |
| 02/21/2008 | CA2656430A1 Nucleic acid encoding n-methylputrescine oxidase and uses thereof |
| 02/20/2008 | EP1889916A1 A method for the production of the recombinant hoxb4 protein containing his tag at c-terminal and use thereof |
| 02/20/2008 | EP1889915A1 APO-2 ligand |
| 02/20/2008 | EP1889909A1 Improvement of disease resistance of plant by introducing transcription factor gene |
| 02/20/2008 | EP1889908A1 Anti-cd14 antibody-fused protein |
| 02/20/2008 | EP1889906A1 High-copy-number, high-expression vector having methionine aminopeptidase gene therein |
| 02/20/2008 | EP1889905A1 Method for amelioration of disease condition induced by mood disorder |
| 02/20/2008 | EP1889902A1 Method for transformation using mutant acetolactate synthase gene |
| 02/20/2008 | EP1889823A1 13c,15n,2h labeled proteins for nmr structure determinations and their preparation |
| 02/20/2008 | EP1889063A2 Nanoscale neuromodulating platform for retina neuron activation apparatus and method |
| 02/20/2008 | EP1888751A2 A hepatitis c virus non-structural ns3/4a fusion gene |
| 02/20/2008 | EP1888750A1 Shrna and sirna expression in a living organism under control op a codon-optimized tetracycline repressor gene |
| 02/20/2008 | EP1888742A1 Liver progenitor cells |
| 02/20/2008 | EP1888741A2 Treatment of ischemia using stem cells |
| 02/20/2008 | EP1888632A2 Cytokine |
| 02/20/2008 | EP1888123A2 A cellular therapy for ocular degeneration |
| 02/20/2008 | EP1887860A2 Murine stem cells and applications thereof |
| 02/20/2008 | EP1789441A4 Notch mutations leading to increased receptor signaling |
| 02/20/2008 | EP1490005B1 Devices for selective disruption of fatty tissue by controlled cooling |
| 02/20/2008 | EP1458867B1 Gene promoters |